NOTCH3 and Cognitive impairment: Interestingly, the proportion of cognitive impairment in patients with NOTCH3 cysteine-sparing mutations was significantly more prevalent (67.47% vs. 35.54%), similar to psychiatric disturbance (38.96% vs. 32.95%).